Company loses cancer gene patent case

October 8, 2015
Issue 
Yvonne D'Arcy whose campaign stopped a company from trying to patent a cancer gene.

A Queensland woman has won a High Court challenge against corporations owning human genes.

Yvonne D'Arcy took her fight against US-based biotech company Myriad Genetics to Australia's highest court. The company has a patent over the BRCA1 gene that is linked to an increased risk of hereditary breast and ovarian cancers.

A Queensland woman has won a High Court challenge against corporations owning human genes.

Yvonne D'Arcy took her fight against US-based biotech company Myriad Genetics to Australia's highest court. The company has a patent over the BRCA1 gene that is linked to an increased risk of hereditary breast and ovarian cancers.

Darcy's lawyers had argued that genetic material is a product of nature and is therefore not patent-able. Allowing corporations to own patents over human genes stifled cancer research, she said, and would allow them to charge exorbitant rates for patients who wish to be tested for the BRCA1 mutation.

In a unanimous decision on October 7, the High Court found that coding for a BRCA1 protein was not a 鈥減atentable invention鈥.

Like the article? Subscribe to 91自拍论坛 now! You can also us on Facebook and on Twitter.

You need 91自拍论坛, and we need you!

91自拍论坛 is funded by contributions from readers and supporters. Help us reach our funding target.

Make a One-off Donation or choose from one of our Monthly Donation options.

Become a supporter to get the digital edition for $5 per month or the print edition for $10 per month. One-time payment options are available.

You can also call 1800 634 206 to make a donation or to become a supporter. Thank you.